APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Function Testing and Evaluation Equipment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pulmonary Function Testing and Evaluation Equipment Market Outlook and Growth Opportunities 2026

Report ID 17442820054 July 2026200 pages

Choose your research edition.

Industry ResearchPulmonary Function Testing and Evaluation Equipment Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Function Testing and Evaluation Equipment Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pulmonary Function Testing and Evaluation Equipment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Function Testing and Evaluation Equipment Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Function Testing and Evaluation Equipment Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Pulmonary Function Testing and Evaluation Equipment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pulmonary Function Testing and Evaluation Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pulmonary Function Testing and Evaluation Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pulmonary Function Testing and Evaluation Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pulmonary Function Testing and Evaluation Equipment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pulmonary Function Testing and Evaluation Equipment market include Medtronic, Welch Allyn, Vyaire Medical, Smiths Medical, Schiller AG, Philips Healthcare, Novelda AS, Nihon Kohden Corporation and MGC Diagnostics Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pulmonary Function Testing and Evaluation Equipment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pulmonary Function Testing and Evaluation Equipment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pulmonary Function Testing and Evaluation Equipment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pulmonary Function Testing and Evaluation Equipment market size, projected growth trends, production technologies, key applications, and end-use industries.

Pulmonary Function Testing and Evaluation Equipment Segment by Company

Medtronic

Welch Allyn

Vyaire Medical

Smiths Medical

Schiller AG

Philips Healthcare

Novelda AS

Nihon Kohden Corporation

MGC Diagnostics Corporation

MGC Diagnostics

Masimo

Ganshorn

Eco Physics

Drägerwerk AG & Co.

Dickinson and Company

COSMED

Becton

Anhui Electric Science

Pulmonary Function Testing and Evaluation Equipment Segment by Type

Pulse Oximeter

Peak Flow Meter

Spirometer

Pulmonary System

Others

Pulmonary Function Testing and Evaluation Equipment Segment by Application

Hospital

Clinic

Others

Pulmonary Function Testing and Evaluation Equipment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pulmonary Function Testing and Evaluation Equipment status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pulmonary Function Testing and Evaluation Equipment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pulmonary Function Testing and Evaluation Equipment significant trends, drivers, influence factors in global and regions.

6. To analyze Pulmonary Function Testing and Evaluation Equipment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Function Testing and Evaluation Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Function Testing and Evaluation Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Function Testing and Evaluation Equipment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pulmonary Function Testing and Evaluation Equipment market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pulmonary Function Testing and Evaluation Equipment industry.

Chapter 3: Detailed analysis of Pulmonary Function Testing and Evaluation Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pulmonary Function Testing and Evaluation Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pulmonary Function Testing and Evaluation Equipment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pulmonary Function Testing and Evaluation Equipment Industry Trends Table 2. Pulmonary Function Testing and Evaluation Equipment Industry Drivers Table 3. Pulmonary Function Testing and Evaluation Equipment Industry Opportunities and Challenges Table 4. Pulmonary Function Testing and Evaluation Equipment Industry Restraints Table 5. Global Pulmonary Function Testing and Evaluation Equipment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pulmonary Function Testing and Evaluation Equipment Revenue Share by Company (2021-2026) Table 7. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Company (2021-2026) Table 9. Global Pulmonary Function Testing and Evaluation Equipment Average Price (USD/unit) of Company (2021-2026) Table 10. Global Pulmonary Function Testing and Evaluation Equipment Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pulmonary Function Testing and Evaluation Equipment Key Company Manufacturing Base & Headquarters Table 12. Global Pulmonary Function Testing and Evaluation Equipment Company, Product Type & Application Table 13. Global Pulmonary Function Testing and Evaluation Equipment Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pulmonary Function Testing and Evaluation Equipment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Pulse Oximeter Table 18. Significant Companies of Peak Flow Meter Table 19. Significant Companies of Spirometer Table 20. Significant Companies of Pulmonary System Table 21. Significant Companies of Others Table 22. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Type (2021-2026) & (k units) Table 24. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Type (2027-2032) & (k units) Table 25. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Type (2021-2026) Table 26. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Type (2027-2032) Table 27. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type (2021-2026) Table 31. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Application (2021-2026) & (k units) Table 37. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Application (2027-2032) & (k units) Table 38. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Application (2021-2026) Table 39. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Application (2027-2032) Table 40. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application (2021-2026) Table 44. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application (2027-2032) Table 45. Global Pulmonary Function Testing and Evaluation Equipment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Pulmonary Function Testing and Evaluation Equipment Sales by Region (2021-2026) & (k units) Table 47. Global Pulmonary Function Testing and Evaluation Equipment Sales Market Share by Region (2021-2026) Table 48. Global Pulmonary Function Testing and Evaluation Equipment Sales by Region (2027-2032) & (k units) Table 49. Global Pulmonary Function Testing and Evaluation Equipment Sales Market Share by Region (2027-2032) Table 50. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Region (2021-2026) Table 53. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Region (2027-2032) Table 55. Global Pulmonary Function Testing and Evaluation Equipment Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Pulmonary Function Testing and Evaluation Equipment Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Pulmonary Function Testing and Evaluation Equipment Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Pulmonary Function Testing and Evaluation Equipment Sales by Country (2021-2026) & (k units) Table 60. Global Pulmonary Function Testing and Evaluation Equipment Sales Market Share by Country (2021-2026) Table 61. Global Pulmonary Function Testing and Evaluation Equipment Sales by Country (2027-2032) & (k units) Table 62. Global Pulmonary Function Testing and Evaluation Equipment Sales Market Share by Country (2027-2032) Table 63. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Market Share by Country (2021-2026) Table 65. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Market Share by Country (2027-2032) Table 67. Medtronic Company Information Table 68. Medtronic Business Overview Table 69. Medtronic Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Medtronic Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 71. Medtronic Recent Development Table 72. Welch Allyn Company Information Table 73. Welch Allyn Business Overview Table 74. Welch Allyn Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Welch Allyn Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 76. Welch Allyn Recent Development Table 77. Vyaire Medical Company Information Table 78. Vyaire Medical Business Overview Table 79. Vyaire Medical Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Vyaire Medical Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 81. Vyaire Medical Recent Development Table 82. Smiths Medical Company Information Table 83. Smiths Medical Business Overview Table 84. Smiths Medical Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Smiths Medical Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 86. Smiths Medical Recent Development Table 87. Schiller AG Company Information Table 88. Schiller AG Business Overview Table 89. Schiller AG Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Schiller AG Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 91. Schiller AG Recent Development Table 92. Philips Healthcare Company Information Table 93. Philips Healthcare Business Overview Table 94. Philips Healthcare Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Philips Healthcare Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 96. Philips Healthcare Recent Development Table 97. Novelda AS Company Information Table 98. Novelda AS Business Overview Table 99. Novelda AS Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Novelda AS Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 101. Novelda AS Recent Development Table 102. Nihon Kohden Corporation Company Information Table 103. Nihon Kohden Corporation Business Overview Table 104. Nihon Kohden Corporation Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Nihon Kohden Corporation Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 106. Nihon Kohden Corporation Recent Development Table 107. MGC Diagnostics Corporation Company Information Table 108. MGC Diagnostics Corporation Business Overview Table 109. MGC Diagnostics Corporation Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. MGC Diagnostics Corporation Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 111. MGC Diagnostics Corporation Recent Development Table 112. MGC Diagnostics Company Information Table 113. MGC Diagnostics Business Overview Table 114. MGC Diagnostics Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. MGC Diagnostics Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 116. MGC Diagnostics Recent Development Table 117. Masimo Company Information Table 118. Masimo Business Overview Table 119. Masimo Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Masimo Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 121. Masimo Recent Development Table 122. Ganshorn Company Information Table 123. Ganshorn Business Overview Table 124. Ganshorn Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Ganshorn Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 126. Ganshorn Recent Development Table 127. Eco Physics Company Information Table 128. Eco Physics Business Overview Table 129. Eco Physics Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Eco Physics Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 131. Eco Physics Recent Development Table 132. Drägerwerk AG & Co. Company Information Table 133. Drägerwerk AG & Co. Business Overview Table 134. Drägerwerk AG & Co. Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Drägerwerk AG & Co. Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 136. Drägerwerk AG & Co. Recent Development Table 137. Dickinson and Company Company Information Table 138. Dickinson and Company Business Overview Table 139. Dickinson and Company Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Dickinson and Company Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 141. Dickinson and Company Recent Development Table 142. COSMED Company Information Table 143. COSMED Business Overview Table 144. COSMED Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. COSMED Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 146. COSMED Recent Development Table 147. Becton Company Information Table 148. Becton Business Overview Table 149. Becton Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Becton Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 151. Becton Recent Development Table 152. Anhui Electric Science Company Information Table 153. Anhui Electric Science Business Overview Table 154. Anhui Electric Science Pulmonary Function Testing and Evaluation Equipment Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Anhui Electric Science Pulmonary Function Testing and Evaluation Equipment Product Portfolio Table 156. Anhui Electric Science Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Pulmonary Function Testing and Evaluation Equipment Distributors List Table 160. Pulmonary Function Testing and Evaluation Equipment Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Pulmonary Function Testing and Evaluation Equipment Product Image Figure 2. Global Pulmonary Function Testing and Evaluation Equipment Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pulmonary Function Testing and Evaluation Equipment Sales (2021-2032) & (k units) Figure 5. Global Pulmonary Function Testing and Evaluation Equipment Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Pulmonary Function Testing and Evaluation Equipment Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Pulse Oximeter Image Figure 10. Peak Flow Meter Image Figure 11. Spirometer Image Figure 12. Pulmonary System Image Figure 13. Others Image Figure 14. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Type (2021-2032) Figure 17. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Application (2021-2032) Figure 26. Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application (2021-2032) Figure 29. Global Pulmonary Function Testing and Evaluation Equipment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Pulmonary Function Testing and Evaluation Equipment Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032) & (US$ Million) Figure 34. North America Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032) & (US$ Million) Figure 40. South America Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Pulmonary Function Testing and Evaluation Equipment Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Pulmonary Function Testing and Evaluation Equipment Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Pulse Oximeter
  • Peak Flow Meter
  • Spirometer
  • Pulmonary System
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Medtronic
  • Welch Allyn
  • Vyaire Medical
  • Smiths Medical
  • Schiller AG
  • Philips Healthcare
  • Novelda AS
  • Nihon Kohden Corporation
  • MGC Diagnostics Corporation
  • MGC Diagnostics
  • Masimo
  • Ganshorn
  • Eco Physics
  • Drägerwerk AG & Co.
  • Dickinson and Company
  • COSMED
  • Becton
  • Anhui Electric Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032)
  4. 1.2.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume (2021-2032)
  5. 1.2.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pulmonary Function Testing and Evaluation Equipment Market Dynamics
  1. 2.1 Pulmonary Function Testing and Evaluation Equipment Industry Trends
  2. 2.2 Pulmonary Function Testing and Evaluation Equipment Industry Drivers
  3. 2.3 Pulmonary Function Testing and Evaluation Equipment Industry Opportunities and Challenges
  4. 2.4 Pulmonary Function Testing and Evaluation Equipment Industry Restraints
3 Pulmonary Function Testing and Evaluation Equipment Market by Company
  1. 3.1 Global Pulmonary Function Testing and Evaluation Equipment Company Revenue Ranking in 2025
  2. 3.2 Global Pulmonary Function Testing and Evaluation Equipment Revenue by Company (2021-2026)
  3. 3.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Company (2021-2026)
  4. 3.4 Global Pulmonary Function Testing and Evaluation Equipment Average Price by Company (2021-2026)
  5. 3.5 Global Pulmonary Function Testing and Evaluation Equipment Company Ranking (2024-2026)
  6. 3.6 Global Pulmonary Function Testing and Evaluation Equipment Company Manufacturing Base and Headquarters
  7. 3.7 Global Pulmonary Function Testing and Evaluation Equipment Company Product Type and Application
  8. 3.8 Global Pulmonary Function Testing and Evaluation Equipment Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pulmonary Function Testing and Evaluation Equipment Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pulmonary Function Testing and Evaluation Equipment Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pulmonary Function Testing and Evaluation Equipment Market by Type
  1. 4.1 Pulmonary Function Testing and Evaluation Equipment Type Introduction
  2. 4.1.1 Pulse Oximeter
  3. 4.1.2 Peak Flow Meter
  4. 4.1.3 Spirometer
  5. 4.1.4 Pulmonary System
  6. 4.1.5 Others
  7. 4.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Type
  8. 4.2.1 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Type
  12. 4.3.1 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Type (2021-2032)
  14. 4.3.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type (2021-2032)
5 Pulmonary Function Testing and Evaluation Equipment Market by Application
  1. 5.1 Pulmonary Function Testing and Evaluation Equipment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Application
  6. 5.2.1 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Application
  10. 5.3.1 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application (2021-2032)
6 Pulmonary Function Testing and Evaluation Equipment Regional Sales and Value Analysis
  1. 6.1 Global Pulmonary Function Testing and Evaluation Equipment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pulmonary Function Testing and Evaluation Equipment Sales by Region (2021-2032)
  3. 6.2.1 Global Pulmonary Function Testing and Evaluation Equipment Sales by Region: 2021-2026
  4. 6.2.2 Global Pulmonary Function Testing and Evaluation Equipment Sales by Region (2027-2032)
  5. 6.3 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Region (2027-2032)
  9. 6.5 Global Pulmonary Function Testing and Evaluation Equipment Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032)
  12. 6.6.2 North America Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032)
  15. 6.7.2 Europe Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032)
  21. 6.9.2 South America Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pulmonary Function Testing and Evaluation Equipment Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Country, 2025 VS 2032
7 Pulmonary Function Testing and Evaluation Equipment Country-level Sales and Value Analysis
  1. 7.1 Global Pulmonary Function Testing and Evaluation Equipment Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pulmonary Function Testing and Evaluation Equipment Sales by Country (2021-2032)
  4. 7.3.1 Global Pulmonary Function Testing and Evaluation Equipment Sales by Country (2021-2026)
  5. 7.3.2 Global Pulmonary Function Testing and Evaluation Equipment Sales by Country (2027-2032)
  6. 7.4 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pulmonary Function Testing and Evaluation Equipment Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pulmonary Function Testing and Evaluation Equipment Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pulmonary Function Testing and Evaluation Equipment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Welch Allyn
  8. 8.2.1 Welch Allyn Company Information
  9. 8.2.2 Welch Allyn Business Overview
  10. 8.2.3 Welch Allyn Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Welch Allyn Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  12. 8.2.5 Welch Allyn Recent Developments
  13. 8.3 Vyaire Medical
  14. 8.3.1 Vyaire Medical Company Information
  15. 8.3.2 Vyaire Medical Business Overview
  16. 8.3.3 Vyaire Medical Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vyaire Medical Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  18. 8.3.5 Vyaire Medical Recent Developments
  19. 8.4 Smiths Medical
  20. 8.4.1 Smiths Medical Company Information
  21. 8.4.2 Smiths Medical Business Overview
  22. 8.4.3 Smiths Medical Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Smiths Medical Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  24. 8.4.5 Smiths Medical Recent Developments
  25. 8.5 Schiller AG
  26. 8.5.1 Schiller AG Company Information
  27. 8.5.2 Schiller AG Business Overview
  28. 8.5.3 Schiller AG Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Schiller AG Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  30. 8.5.5 Schiller AG Recent Developments
  31. 8.6 Philips Healthcare
  32. 8.6.1 Philips Healthcare Company Information
  33. 8.6.2 Philips Healthcare Business Overview
  34. 8.6.3 Philips Healthcare Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Philips Healthcare Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  36. 8.6.5 Philips Healthcare Recent Developments
  37. 8.7 Novelda AS
  38. 8.7.1 Novelda AS Company Information
  39. 8.7.2 Novelda AS Business Overview
  40. 8.7.3 Novelda AS Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Novelda AS Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  42. 8.7.5 Novelda AS Recent Developments
  43. 8.8 Nihon Kohden Corporation
  44. 8.8.1 Nihon Kohden Corporation Company Information
  45. 8.8.2 Nihon Kohden Corporation Business Overview
  46. 8.8.3 Nihon Kohden Corporation Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nihon Kohden Corporation Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  48. 8.8.5 Nihon Kohden Corporation Recent Developments
  49. 8.9 MGC Diagnostics Corporation
  50. 8.9.1 MGC Diagnostics Corporation Company Information
  51. 8.9.2 MGC Diagnostics Corporation Business Overview
  52. 8.9.3 MGC Diagnostics Corporation Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 MGC Diagnostics Corporation Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  54. 8.9.5 MGC Diagnostics Corporation Recent Developments
  55. 8.10 MGC Diagnostics
  56. 8.10.1 MGC Diagnostics Company Information
  57. 8.10.2 MGC Diagnostics Business Overview
  58. 8.10.3 MGC Diagnostics Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 MGC Diagnostics Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  60. 8.10.5 MGC Diagnostics Recent Developments
  61. 8.11 Masimo
  62. 8.11.1 Masimo Company Information
  63. 8.11.2 Masimo Business Overview
  64. 8.11.3 Masimo Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Masimo Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  66. 8.11.5 Masimo Recent Developments
  67. 8.12 Ganshorn
  68. 8.12.1 Ganshorn Company Information
  69. 8.12.2 Ganshorn Business Overview
  70. 8.12.3 Ganshorn Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ganshorn Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  72. 8.12.5 Ganshorn Recent Developments
  73. 8.13 Eco Physics
  74. 8.13.1 Eco Physics Company Information
  75. 8.13.2 Eco Physics Business Overview
  76. 8.13.3 Eco Physics Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Eco Physics Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  78. 8.13.5 Eco Physics Recent Developments
  79. 8.14 Drägerwerk AG & Co.
  80. 8.14.1 Drägerwerk AG & Co. Company Information
  81. 8.14.2 Drägerwerk AG & Co. Business Overview
  82. 8.14.3 Drägerwerk AG & Co. Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Drägerwerk AG & Co. Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  84. 8.14.5 Drägerwerk AG & Co. Recent Developments
  85. 8.15 Dickinson and Company
  86. 8.15.1 Dickinson and Company Company Information
  87. 8.15.2 Dickinson and Company Business Overview
  88. 8.15.3 Dickinson and Company Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Dickinson and Company Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  90. 8.15.5 Dickinson and Company Recent Developments
  91. 8.16 COSMED
  92. 8.16.1 COSMED Company Information
  93. 8.16.2 COSMED Business Overview
  94. 8.16.3 COSMED Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 COSMED Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  96. 8.16.5 COSMED Recent Developments
  97. 8.17 Becton
  98. 8.17.1 Becton Company Information
  99. 8.17.2 Becton Business Overview
  100. 8.17.3 Becton Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Becton Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  102. 8.17.5 Becton Recent Developments
  103. 8.18 Anhui Electric Science
  104. 8.18.1 Anhui Electric Science Company Information
  105. 8.18.2 Anhui Electric Science Business Overview
  106. 8.18.3 Anhui Electric Science Pulmonary Function Testing and Evaluation Equipment Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Anhui Electric Science Pulmonary Function Testing and Evaluation Equipment Product Portfolio
  108. 8.18.5 Anhui Electric Science Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pulmonary Function Testing and Evaluation Equipment Value Chain Analysis
  2. 9.1.1 Pulmonary Function Testing and Evaluation Equipment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pulmonary Function Testing and Evaluation Equipment Sales Mode & Process
  6. 9.2 Pulmonary Function Testing and Evaluation Equipment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pulmonary Function Testing and Evaluation Equipment Distributors
  9. 9.2.3 Pulmonary Function Testing and Evaluation Equipment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst